medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Дек. 12, 2024
Abstract
Functional
connectivity
magnetic
resonance
imaging
(fcMRI)
is
a
well-established
technique
for
studying
brain
networks
in
both
healthy
and
diseased
individuals.
However,
no
fcMRI-based
biomarker
has
yet
achieved
clinical
relevance.
To
establish
better
understanding
of
the
state
art
quantifying
abnormal
comparison
to
reference
distribution,
potential
use
individual
patients,
we
have
conducted
scoping
review
over
5672
entries
from
last
10
years.
We
located
five
publications
proposing
methods
quantification,
reported
these
formalized
them.
also
illustrated
emerging
trends
technical
innovations
fcMRI
research
that
may
facilitate
development
individualized
metrics.
JAMA Psychiatry,
Год журнала:
2023,
Номер
80(12), С. 1246 - 1246
Опубликована: Сен. 20, 2023
Psychotic
illness
is
associated
with
anatomically
distributed
gray
matter
reductions
that
can
worsen
progression,
but
the
mechanisms
underlying
specific
spatial
patterning
of
these
changes
unknown.
Translational Psychiatry,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 24, 2025
Abstract
Schizophrenia
spectrum
disorders
(SSD)
involve
disturbances
in
the
integration
of
perception,
emotion
and
cognition.
The
corticolimbic
system
is
an
interacting
set
cortical
subcortical
brain
regions
critically
involved
this
process.
Understanding
how
neural
circuitry
molecular
mechanisms
within
may
contribute
to
development
not
only
positive
symptoms
but
also
negative
cognitive
deficits
SSD
has
been
a
recent
focus
intense
research,
as
latter
are
adequately
treated
by
current
antipsychotic
medications
more
strongly
associated
with
poorer
functioning
long-term
outcomes.
This
review
synthesises
developments
examining
dysfunction
pathophysiology
SSD,
on
neuroimaging
advances
related
novel
methodologies
that
enable
data
across
different
scales.
We
then
integrate
these
findings
inform
identification
therapeutic
preventive
targets
for
symptomatology.
A
range
pharmacological
interventions
have
shown
initial
promise
correcting
improving
negative,
treatment-resistant
symptoms.
discuss
challenges
opportunities
still
limited
translation
research
into
clinical
practice.
argue
our
knowledge
role
can
be
improved
combining
multiple
modalities
examine
hypotheses
spatial
temporal
scales,
experimental
utilising
large-scale
consortia
advance
biomarker
identification.
Translation
practice
will
aided
consideration
optimal
intervention
timings,
biomarker-led
patient
stratification,
selective
medications.
Biological Psychiatry,
Год журнала:
2024,
Номер
unknown
Опубликована: Янв. 1, 2024
Schizophrenia
is
a
chronic
mental
illness
that
affects
up
to
1%
of
the
population.
While
efficacious
therapies
are
available
for
positive
symptoms,
effective
treatment
cognitive
and
negative
symptoms
remains
an
unmet
need
after
decades
research.
New
developments
in
field
neuroimaging
accelerating
our
knowledge
gain
regarding
underlying
pathophysiology
schizophrenia
psychosis
spectrum
disorders,
inspiring
new
targets
drug
development.
However,
no
validated
qualified
biomarkers
currently
support
development
therapeutics.
This
review
summarizes
current
use
technology
clinical
psychotic
disorders.
As
exemplified
by
programs
target
NMDA
receptor
hypofunction,
results
play
critical
role
discovery
establishing
engagement
dose
selection.
Furthermore,
pharmacological
may
provide
response
allow
early
decision
making
proof-of-concept
studies
leverage
challenge
models
healthy
volunteers.
That
said,
while
predictive
starting
be
evaluated
patient
populations,
they
continue
limited
role.
Novel
approaches
data
acquisition
analysis
aid
establishment
at
individual
level
future.
Nevertheless,
various
gaps
addressed
establish
them
as
"fit
purpose"
Brain Sciences,
Год журнала:
2024,
Номер
14(12), С. 1196 - 1196
Опубликована: Ноя. 27, 2024
Schizophrenia,
a
highly
complex
psychiatric
disorder,
presents
significant
challenges
in
diagnosis
and
treatment
due
to
its
multifaceted
neurobiological
underpinnings.
Recent
advancements
functional
magnetic
resonance
imaging
(fMRI)
artificial
intelligence
(AI)
have
revolutionized
the
understanding
management
of
this
condition.
This
manuscript
explores
how
integration
these
technologies
has
unveiled
key
insights
into
schizophrenia’s
structural
neural
anomalies.
fMRI
research
highlights
disruptions
crucial
brain
regions
like
prefrontal
cortex
hippocampus,
alongside
impaired
connectivity
within
networks
such
as
default
mode
network
(DMN).
These
alterations
correlate
with
cognitive
deficits
emotional
dysregulation
characteristic
schizophrenia.
AI
techniques,
including
machine
learning
(ML)
deep
(DL),
enhanced
detection
analysis
patterns,
surpassing
traditional
methods
precision.
Algorithms
support
vector
machines
(SVMs)
Vision
Transformers
(ViTs)
proven
particularly
effective
identifying
biomarkers
aiding
early
diagnosis.
Despite
advancements,
variability
methodologies
disorder’s
heterogeneity
persist,
necessitating
large-scale,
collaborative
studies
for
clinical
translation.
Moreover,
ethical
considerations
surrounding
data
integrity,
algorithmic
transparency,
patient
individuality
must
guide
AI’s
psychiatry.
Looking
ahead,
AI-augmented
holds
promise
tailoring
personalized
interventions,
addressing
unique
dysfunctions,
improving
therapeutic
outcomes
individuals
convergence
neuroimaging
computational
innovation
heralds
transformative
era
precision
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 17, 2025
A
bstract
Temporal
lobe
epilepsy
with
hippocampal
sclerosis
(TLE-HS)
is
associated
a
complex
genetic
architecture,
but
the
translation
from
risk
factors
to
brain
vulnerability
remains
unclear.
Here,
we
examined
associations
between
epilepsy-related
polygenic
scores
for
HS
(PRS-HS)
and
structure
in
large
sample
of
neurotypical
children,
correlated
these
signatures
case-control
findings
multicentric
cohorts
patients
TLE-HS.
Imaging-genetic
analyses
revealed
PRS-related
cortical
thinning
temporo-parietal
fronto-central
regions,
strongly
anchored
distinct
functional
structural
network
epicentres.
Compared
disease-related
effects
derived
cohorts,
correlates
PRS-HS
mirrored
atrophy
epicentre
patterns
By
identifying
potential
pathway
disease
mechanisms,
our
provide
new
insights
into
underpinnings
alterations
TLE-HS
highlight
imaging-genetic
biomarkers
early
stratification
personalized
interventions.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 21, 2025
Abstract
Growing
evidence
suggests
abnormalities
of
brain
structural
connectome
in
psychiatric
disorders,
but
the
causal
relationships
remain
underexplored.
We
conducted
bidirectional
two-sample
Mendelian
randomization
(MR)
analyses
to
investigate
links
between
206
white-matter
connectivity
phenotypes
(n
=
26,333,
UK
Biobank)
and
13
major
disorders
14,307
1,222,882).
Forward
MR
identified
effects
genetically
predicted
five
on
six
with
associations
being
significant
or
suggestive.
For
instance,
left-hemisphere
frontoparietal
control
network
right-hemisphere
default
mode
was
significantly
negatively
associated
autism
spectrum
disorder
risk,
while
increased
hippocampus
linked
decreased
anorexia
nervosa
cannabis
use
risk.
Reverse
revealed
suggestively
risk
two
four
different
phenotypes.
example,
susceptibility
found
be
visual
pallidum.
These
findings
offer
new
insights
into
etiology
highlight
potential
biomarkers
for
early
detection
prevention
at
level.
Temporal
lobe
epilepsy
(TLE)
has
been
recognized
as
a
network
disorder
with
widespread
gray
matter
atrophy.
However,
the
role
of
connectome
architecture
in
shaping
morphological
alterations
and
identifying
atrophy
epicenters
remains
unclear.
Furthermore,
individualized
modeling
their
potential
clinical
applications
have
not
well
established.
This
study
aims
to
explore
how
correlates
normal
architecture,
identify
epicenters,
employ
approach
evaluate
impact
different
epicenter
patterns
on
surgical
outcomes
patients
TLE.
utilized
anatomic
MRI
data
from
126
refractory
TLE
who
underwent
anterior
temporal
lobectomy
60
healthy
controls
(HCs),
along
normative
functional
structural
data,
investigate
relationship
between
volume
(GMV)
changes
or
connectivity.
Two
models
were
employed
epicenters:
data-driven
evaluating
nodal
neighbor
rankings,
diffusion
model
(NDM)
simulating
spread
pathology
seed
regions.
K-means
clustering
was
applied
patient-tailored
uncover
distinct
subtypes.
Our
findings
indicate
that
pattern
is
constrained
primarily
by
connectivity
rather
than
Using
connectome,
we
pinpointed
hippocampus
adjacent
temporo-limbic
regions
key
epicenters.
The
revealed
significant
variability
distribution,
allowing
us
categorize
them
into
two
Notably,
subtype
2,
localized
ipsilateral
pole
medial
lobe,
exhibited
significantly
higher
seizure-free
rates
compared
1,
whose
situated
frontocentral
These
highlight
central
TLE-related
changes.
Individualized
may
enhance
decisions
improve
prognostic
stratification
management.
Auditory
verbal
hallucinations
(AVHs)
are
experienced
by
the
majority
of
patients
with
schizophrenia
and
often
resistant
to
treatment
antipsychotic
agents.
White
matter
(WM)
tract
abnormalities
associated
AVH
efficacy.
Using
a
retrospective
design,
115
AVHs,
48
medication-resistant
AVHs
67
treatable
70
healthy
controls
(HCs)
were
selected
from
database
our
cohort
study
for
5-year
follow-up
assessment.
WM
integrity
was
measured
using
tract-based
spatial
statistics
(TBSS)
at
baseline
after
5
years
agent
treatment.
The
fractional
anisotropy
(FA)
value
used
demonstrate
alterations
in
HCs.
Our
data
demonstrated
that
showed
significantly
greater
FA
values
corpus
callosum
(CC)
fasciculus
corticospinal
post-treatment
compared
HCs,
but
difference
CC
no
longer
significant
group
exhibited
superior
longitudinal
Compared
HC
group,
visual
radiation
In
groups,
common
noted,
as
observed
group.
At
same
time,
distinct
fasciculus,
which
may
contribute
whereas
both
AVHs.
decrease
posterior
observation
baseline.
summary,
treatment-resistant
have
tract.
Automated
MRI
analyses
have
identified
variable
patterns
of
cortical
atrophy
in
Rasmussen
syndrome.
In
this
study,
we
aim
to
identify
imaging
phenotypes
syndrome,
clinically
characterize
these
phenotypes,
and
validate
imaging-based
approach
through
histopathologic
analysis.
For
retrospective
case-control
individuals
with
syndrome
diagnosed
according
the
European
Consensus
Statement
at
least
one
3D
T1-weighted
scan
(<20
years
after
onset)
were
from
University
Hospital
Bonn
(1995-2023).
Healthy
controls
selected
databases
Bonn,
Charité
Berlin,
Human
Connectome
Project.
Disease
epicenters,
describing
brain
regions
highly
connected
regions,
mapped
individually
using
network-based
modeling.
Subtypes
k-means
clustering.
Neuropsychological
test
results
neuropathologic
biopsies
ascertained,
correlations
between
subtype-specific
maps
normative
(enhancing
neuro
genetics
meta
analysis
[ENIGMA]
neuromaps
toolbox)
used
profiles
epicenter
susceptibility.
The
study
incorporated
54
(median
age
MRI:
18
years,
range
2-61,
65%
female)
270
healthy
26.5
3-61,
49%
female).
Four
distinct
subtypes
(temporoparietal,
centrotemporal,
frontal,
bilateral).
Individuals
centrotemporal
subtype
younger
onset
5.5
years)
than
temporoparietal
11.5
p
=
0.02)
frontal
6
subtypes.
Most
severe
neuropsychological
impairment
was
observed
for
subtypes,
occurred
preferentially
hubs
(r
-0.28,
0.006;
r
-0.30,
0.02).
susceptibility
associated
higher
thickness
-0.57,
0.005),
lower
myelin
content
0.47,
0.02),
cerebral
blood
flow
0.42,
0.03),
volume
0.57,
0.006),
oxygen
metabolism
0.01).
Brain
showing
strong
inflammation
taken
likely
whereas
weaker
came
less
epicenters
(p
0.04).
Using
as
a
model,
mapping
individual
disease
evidence.
With
further
validation,
could
potentially
be
guide
biopsy
site
selection,
inform
treatment
decisions,
improve
outcome
prognoses.